Tag Archives: Early Advantage

  • Nick Hodge’s “The one and ONLY move to turn $10,000 into $1 million on the lithium energy boom.”

    Before gold and silver started taking off a few months ago, lithium had been the only non-disappointing commodity investment around for quite a while… and we covered a bunch of teasers for lithium producers and explorers over the past year, most of which were built on the “Tesla’s gigafactory is going to need more lithium […]

  • “The ‘5 Cents to $109 a Share’ Insider Deals You Never Hear About…”

    Nick Hodge is out with a teaser pitch for another “upgrade” newsletter he’s selling — this time, the upgrade is only available for folks who already subscribe to his Early Advantage newsletter, which is where he used to pitch his speculative microcaps. Early Advantage is $999/year, and that’s the one that’s still pitching “Obama’s Secret […]

  • Wireless Electricity and the “Midas Supergroup”

    “America’s Most Elite Investment Collective Just Netted 67,350% Gains… “And it’s about to do it again! “Thanks to a proprietary investment ranking tool, this group has its hands on a game-changing technology… “And it’s about to take early investors for another ridiculous profit ride “They’re called the Midas Supergroup… “And they DO NOT miss. “When […]

  • “GigaProfits! — One tiny resource company essential to the Gigafactory”

    “Tesla is building the largest battery factory ever… “Groundbreaking is expected any day now. You could see… “GigaProfits! “It doesn’t matter what you think about electric cars… You could make a fortune off Tesla’s new $5 billion ‘Gigafactory’ — Even if it’s a colossal failure. “One tiny resource company is essential to the Gigafactory. Here’s […]

  • “Blue Blood” — Which “Tiny Biotech Owns Only Source of Rare Cancer-Curing Chemical?”

    The following article originally appeared on February 11, 2014 — several readers have asked about the “blue blood” pitch for this “cancer cure” (there’s a reason why we use quotes there) so we’re putting it on top of the page in case you’re curious. My opinion on this one is unchanged, I’m still pretty skeptical […]

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.